pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›OXYCODONE AND ACETAMINOPHEN
drug · small molecule
save

OXYCODONE AND ACETAMINOPHEN

updated 3mo ago
by $IGC IGC Pharma, Inc.🔗 ChEMBL
community read0 votes

🐶 often sniffed alongside

top 8
  • drugHYDROCODONE BITARTRATE AND ACETAMINOPHEN660 co-mentions · 335 sources
  • tagApproval648 co-mentions · 324 sources
  • drugXTAMPZA ER326 co-mentions · 326 sources
  • drugoxycodone ER326 co-mentions · 326 sources
  • tagSmall Molecule324 co-mentions · 324 sources
  • companyActavis Elizabeth LLC43 co-mentions · 43 sources
  • companySpecGx LLC19 co-mentions · 18 sources
  • companyAurolife Pharma LLC15 co-mentions · 15 sources

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 18 approved and 81 investigational indications.

targets

CyclooxygenaseFatty-acid amide hydrolase 1Transient receptor potential cation channel subfamily V member 1

all catalysts(0)

nothing on the calendar yet

Trials studying OXYCODONE AND ACETAMINOPHEN

  • phase3A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)recruitingn=770
  • phase3A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With ISN/RPS 2003 Class III or IV Lupus Nephritisactive not recruitingn=271
  • phase1A Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become Pregnantnot yet recruitingn=40
  • phase3A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)recruitingn=340
  • phase2A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participantsrecruitingn=40
  • phase3A Study of Combogesic® IV (Intravenous) in Pediatric Patients With Acute Painnot yet recruitingn=60
  • phase1A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesityrecruitingn=50
  • phase2A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)recruitingn=230
more trials →

News(3)

  • STAT+: Latigo reports mid-stage success for would-be rival to Vertex’s pain drug Journavx
    Latigo Biotherapeutics published positive data for an acute-pain drug meant to rival a Vertex medicine already on the market
    stat · 16d ago
  • STAT+: TrumpRx adds generic drugs
    A deal with Mark Cuban, Amazon Pharmacy, and GoodRx is boosting TrumpRx's offerings.
    stat · 2mo ago
  • STAT+: In her own words: Surgeon general nominee Nicole Saphier expresses enthusiasm and caution for MAHA
    Examining the past statements and writings of Trump's third surgeon general nominee, Dr. Nicole Saphier, on vaccines, autism, peptides, diet and more.
    stat · 3mo ago
brand
OXYCODONE AND ACETAMINOPHEN
trade names
Abdine, Acephen, Acetaminophen, Acetaminophen component of allay, Acetaminophen component of anexsia, Acetaminophen component of anoquan
generic
ACETAMINOPHEN
MOA
Cyclooxygenase inhibitor; Anandamide amidohydrolase inhibitor; Vanilloid receptor opener
indication
INDICATIONS AND USAGE Oxycodone and Acetaminophen Tablets is indicated for the relief of moderate to moderately severe pain.
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 16m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?